These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21784708)

  • 41. Comparative study of prescribing patterns of tigecycline for trial patients versus non-trial patients.
    Horscht JJ; Zimmermann JB; Weigand MA; Bruckner T; Martin EO; Hoppe-Tichy T; Swoboda S
    In Vivo; 2014; 28(4):589-94. PubMed ID: 24982227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution.
    Chemaly RF; Hanmod SS; Jiang Y; Rathod DB; Mulanovich V; Adachi JA; Rolston KV; Raad II; Hachem RY
    Medicine (Baltimore); 2009 Jul; 88(4):211-220. PubMed ID: 19593226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Cai Y; Wang R; Liang B; Bai N; Liu Y
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1162-72. PubMed ID: 21173186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excess deaths associated with tigecycline after approval based on noninferiority trials.
    Prasad P; Sun J; Danner RL; Natanson C
    Clin Infect Dis; 2012 Jun; 54(12):1699-709. PubMed ID: 22467668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. Preface.
    Johnson AP; Leibovici L
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii1. PubMed ID: 23930279
    [No Abstract]   [Full Text] [Related]  

  • 46. [Tigecycline--a new antibiotic].
    Skibeli V; Aaløkken I; Lingaas E; Midtvedt T; Solberg CO; Melby KK
    Tidsskr Nor Laegeforen; 2010 Aug; 130(16):1624-6. PubMed ID: 20805861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tigecycline: benefits and risks.
    Cai Y; Wang R
    Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707
    [No Abstract]   [Full Text] [Related]  

  • 48. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis.
    Zha L; Pan L; Guo J; French N; Villanueva EV; Tefsen B
    Adv Ther; 2020 Mar; 37(3):1049-1064. PubMed ID: 32006240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tigecycline: Alone or in combination?
    Cai Y; Bai N; Liu X; Liang B; Wang J; Wang R
    Infect Dis (Lond); 2016 Jul; 48(7):491-502. PubMed ID: 26982103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases.
    Sipahi OR; Kahraman H; Mermer S; Pullukcu H; Tasbakan M; Arda B; Yamazhan T; Yurtseven T; Aydemir S; Ulusoy S
    Int J Infect Dis; 2014 Jun; 23():16-9. PubMed ID: 24657273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing frequency of Pseudomonas aeruginosa infections during tigecycline use.
    Ulu-Kilic A; Alp E; Altun D; Cevahir F; Kalın G; Demiraslan H
    J Infect Dev Ctries; 2015 Mar; 9(3):309-12. PubMed ID: 25771470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.
    Matthews P; Alpert M; Rahav G; Rill D; Zito E; Gardiner D; Pedersen R; Babinchak T; McGovern PC;
    BMC Infect Dis; 2012 Nov; 12():297. PubMed ID: 23145952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tigecycline use in serious nosocomial infections: a drug use evaluation.
    Bassetti M; Nicolini L; Repetto E; Righi E; Del Bono V; Viscoli C
    BMC Infect Dis; 2010 Sep; 10():287. PubMed ID: 20920273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline.
    Falagas ME; Karageorgopoulos DE; Dimopoulos G
    Curr Drug Metab; 2009 Jan; 10(1):13-21. PubMed ID: 19149509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection.
    Wach J; Dinh A; Dutronc H; Sipahi OR; Candevir A; Valour F; Zeller V; Lustig S; Laurent F; Chidiac C; Ferry T;
    Med Mal Infect; 2018 Feb; 48(1):53-57. PubMed ID: 29031650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A practice-based observational study identifying factors associated with the use of high-dose tigecycline in the treatment of secondary peritonitis in severely ill patients.
    Maseda E; Suárez-de-la-Rica A; Anillo V; Salgado P; Tamayo E; García-Bernedo CA; Ramasco F; Villagrán MJ; López-Tofiño A; Giménez MJ; Granizo JJ; Hernández-Gancedo C; Aguilar L; Gilsanz F
    Rev Esp Quimioter; 2015 Feb; 28(1):47-53. PubMed ID: 25690145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].
    Moya Cordero P; Ruiz-Aragón J; Molina Linde JM; Márquez-Peláez S; Motiva Sánchez V
    Rev Chilena Infectol; 2013 Dec; 30(6):591-7. PubMed ID: 24522299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial.
    Qvist N; Warren B; Leister-Tebbe H; Zito ET; Pedersen R; McGovern PC; Babinchak T
    Surg Infect (Larchmt); 2012 Apr; 13(2):102-9. PubMed ID: 22439781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tigecycline: place in therapy and important considerations.
    Garrelts JC; Schroeder T
    Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospital.
    Grau S; Conde-Estévez D; Luque S; Alvarez-Lerma F; Horcajada JP; Mateu-De Antonio J; Berenguer N; Salas E
    J Chemother; 2010 Oct; 22(5):339-44. PubMed ID: 21123158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.